TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Sana Pharma Sverige AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
671
|
576
|
623 |
| Financial expenses |
1
|
1
|
0 |
| Earnings before taxes |
-119
|
13
|
0 |
| EBITDA |
-116
|
16
|
2 |
| Total assets |
1,423
|
900
|
319 |
| Current assets |
1,419
|
899
|
316 |
| Current liabilities |
1,334
|
864
|
296 |
| Equity capital |
89
|
36
|
23 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
5
|
4
|
4 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
6.3%
|
4.0%
|
7.2% |
| Turnover per employee |
134
|
144
|
156 |
| Profit as a percentage of turnover |
-17.7%
|
2.3%
|
0% |
| Return on assets (ROA) |
-8.3%
|
1.6%
|
0% |
| Current ratio |
106.4%
|
104.1%
|
106.8% |
| Return on equity (ROE) |
-133.7%
|
36.1%
|
0% |
| Change turnover |
114
|
-48
|
363 |
| Change turnover % |
20%
|
-8%
|
140% |
| Chg. No. of employees |
1
|
0
|
1 |
| Chg. No. of employees % |
25%
|
0%
|
33% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.